Global Recombinant Vaccines Market Is Expected to Reach $24.7 Billion by 2031: Says AMR
globenewswire.com
science
2022-10-21 15:30:00

Portland, OR, Oct. 21, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Recombinant Vaccines Market generated $8.1 billion in 2021 and is estimated to hit $24.7 billion by 2031, registering a CAGR of 11.4% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.
